FDA Drug Safety Podcast: FDA warns about several safety issues with opioid pain medicines; requires label changes

On March 22, 2016, FDA announced warnings about several safety issues with the entire class of opioid pain medicines. These safety risks are potentially harmful interactions with numerous other medications, problems with the adrenal glands, and decreased sex hormone levels. We are requiring changes to the labels of all opioid drugs to warn about these risks.
Source: FDA Drug Safety Podcasts